Highly biocompatible luminescent superparamagnetic nanocomposites have been synthesized from Fe 3 O 4 / SiO 2 -QDs (IQ). Fe 3 O 4 nanoparticles coated with a silica shell, Fe 3 O 4 /SiO 2 (IOS), and water-soluble CdSe-ZnS quantum dots (QDs) were assembled together by the conjugation of an SH group. X-ray diffraction (XRD), transmission electron microscopy (TEM), energy-dispersive X-ray analysis (EDX), UV-vis absorption and emission spectroscopy, and magnetometry were applied to characterize the nanocomposites. The nanocomposites exhibited multifunctional superparamagnetic and photoluminescent properties. Bright orange IQ nanoparticles were found to be successfully uptaken into pancreatic human cancer cells (Panc-1) after 24 h incubation. The IQ nanocomposites showed virtually no cytotoxicity toward the Panc-1 cells when the exposure concentration was below 50 µg/mL or 200 µg/mL as determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) or lactate dehydrogenase (LDH) release measurements. After the inclusion of a very low dose (1.66 µg /ml) of fluorescent magnetic nanocomposites and exposure to a radio frequency (RF) treatment for only 2 min, most of the Panc-1 cells (99.2%) were found to die. The apoptosis process can be traceable because of the unique optical properties of the water-soluble IQs. It was also confirmed that the structure-controlled IQ nanocomposites have reasonable magnetic properties, self-heating temperature-rising characteristics, and high biocompatibility. This suggests that these IQ nanocomposites may be considered as biopotential materials for applications involving in vivo nanohyperthermia and cancer treatment.

Supercapacitors are beneficial as energy storage devices and can obtain high capacitance values greater than conventional capacitors and high power densities compared to batteries. However, in order to improve upon the overall cost, energy density, and charge-discharge rates, the electrode material of supercapacitors needs to be fine-tuned with an inexpensive, high conducting source. We prepared a Co(III) complex and polypyrrole (PPy) composite thin films (CoN 4 - PPy) that was electrochemically deposited on the surface of a glassy carbon working electrode. Cyclic voltammetry studies indicate the superior performance of CoN 4 -PPy in charge storage in acidic electrolyte compared to alkaline and organic solutions. The CoN 4 -PPy material generated the highest amount of specific capacitance (up to 721.9 F/g) followed by Co salt and PPy (Co-PPy) material and PPy alone. Cyclic performance studies showed the excellent electrochemical stability of the CoN 4 -PPy film in the acidic medium. Simply electrochemically depositing an inexpensive Co(III) complex with a high electrically conducting polymer of PPy delivered a superior electrode material for supercapacitor applications. Therefore, the results indicate that novel thin films derived from Co(III) metal complex and PPy can store a large amount of energy and maintain high stability over many cycles, revealing its excellent potential in supercapacitor devices.

Dendritic cells (DCs) can acquire, process, and present antigens to T-cells to induce an immune response. For this reason, targeting cancer antigens to DCs in order to cause an immune response against cancer is an emerging area of nanomedicine that has the potential to redefine the way certain cancers are treated. The use of plasmonically active silver-coated gold nanorods (henceforth referred to as plasmonic nano vectors (PNVs)) as potential carriers for DC tumor vaccines has not been presented before. Effective carriers must be able to be phagocytized by DCs, present low toxicity, and induce the maturation of DCs—an early indication of an immune response. When we treated DCs with the PNVs, we found that the cell viability of DCs was unaffected, up to 200 μg/ml. Additionally, the PNVs associated with the DCs as they were phagocytized and they were found to reside within intracellular compartments such as endosomes. More importantly, the PNVs were able to induce expression of surface markers indicative of DC activation and maturation, i.e. CD40, CD86, and MHC class II. These results provide the first evidence that PNVs are promising carriers for DC-based vaccines and warrant further investigating for clinical use.

A wide variety of biomaterials are utilized in tissue engineering to promote cell proliferations in vitro or tissue growth in vivo. The combination of cells, extracellular matrices, and biocompatible materials may make it possible to grow functional living tissues ranging from bone to nerve cells. In bone regeneration, polymeric scaffolds can be enhanced by the addition of bioactive materials. To this end, this study designed several ratios of polyurethane (PU) and nano-hydroxyapatite (nHA) composites (PU-nHA ratios: 100/0, 90/10, 80/20, 70/30, 60/40 w/w). The physical and mechanical properties of these composites and their relative cellular compatibility in vitro were determined. The chemical composition and crystallinity of the composites were confirmed using X-ray diffraction, X-ray photoelectron spectroscopy, and thermogravimetric analyses. Atomic force microscopy, nano-indentation, and contact angle measurements were used to evaluate surface properties. The results showed a significant increase in surface roughness and a decrease in contact angle when the nHA concentration increased above 20%, resulting in a significant increase in hydrophilicity. These surface property changes influenced cellular behavior when MC 3T3-E1 cells were seeded on the composites. All composites were cytocompatible. There was a linear increase in cell proliferation on the 80/20 and 70/30 composites only, whereas subjective evaluation demonstrated noticeable clusters or nodules of cells (considered hallmarks of osteogenic differentiation) in the absence of any osteogenic inducers only on the 90/10 and 80/20 composites. Cellular data suggests that the 80/20 composite was an optimal environment for cell adhesion, proliferation, and, potentially, osteogenic differentiation in vitro.

Hybrid nanocomposite films of ITO-coated, self-assembled porous nanostructures of tungsten trioxide (WO(3)) were fabricated using electrochemical anodization and sputtering. The morphology and chemical nature of the porous nanostructures were studied by Scanning Electron Microscopy (SEM) and X-ray Photoelectron Spectroscopy (XPS), respectively. The photoelectrochemical (PEC) properties of WO(3) porous nanostructures were studied in various alkaline electrolytes and compared with those of titania nanotubes. A new type of alkaline electrolyte containing a mixture of NaOH and KOH was proposed for the first time to the best of our knowledge and shown to improve the photocurrent response of the photoanodes. Here, we show that both the WO(3) nanostructures and titania nanotubes (used for comparison) exhibit superior photocurrent response in the mixture of NaOH and KOH than in other alkaline electrolytes. The WO(3) porous nanostructures suffered from surface corrosion resulting in a huge reduction in the photocurrent density as a function of time in the alkaline electrolytes. However, with a protective coating of ITO (100 nm), the surface corrosion of WO(3) porous nanostructures reduced drastically. A tremendous increase in the photocurrent density of as much as 340% was observed after the ITO was applied to the WO(3) porous nanostructures. The results suggest that the hybrid ITO/WO(3) nanocomposites could be potentially coupled with titania nanotubes in a multi-junction PEC cell to expand the light absorption capability in the solar spectrum for water splitting to generate hydrogen.

The nature of water interaction with tungsten nanorods (WNRs) fabricated by the glancing-angle deposition technique (GLAD)-using RF magnetron sputtering under various Ar pressures and substrate tilting angles and then subsequent coating with Teflon-has been studied and reported. Such nanostructured surfaces have shown strong water repellency properties with apparent water contact angles (AWCA) of as high as 160°, which were found to depend strongly upon the fabrication conditions. Variations in Ar pressure and the substrate tilting angle resulted in the generation of WNRs with different surface roughness and porosity properties. A theoretical model has been proposed to predict the observed high AWCAs measured at the nanostructure interfaces. The unique pyramidal tip geometry of WNRs generated at low Ar pressure with a high oblique angle reduced the solid fraction at the water interface, explaining the high AWCA measured on such surfaces. It was also found that the top geometrical morphologies controlling the total solid fraction of the WNRs are dependent upon and controlled by both the Ar pressure and substrate tilting angle. The water repellency of the tungsten nanorods with contact angles as high as 160° suggests that these coatings have enormous potential for robust superhydrophobic and anti-icing applications in harsh environments.

Advances in anticancer chemotherapy have been hindered by the lack of biocompatibility of new prospective drugs. One significant challenge concerns water insolubility, which compromises the bioavailability of the drugs leading to increased dosage and higher systemic toxicity. To overcome these problems, nanodelivery has been established as a promising approach for increasing the efficacy and lowering the required dosage of chemotherapeutics. The naturally derived compound, parthenolide (PTL), is known for its anti-inflammatory and anticancer activity, but its poor water solubility limits its clinical value. In the present study, we have used carboxyl-functionalized nanographene (fGn) delivery to overcome the extreme hydrophobicity of this drug. A water-soluble PTL analog, dimethylamino parthenolide (DMAPT), was also examined for comparison with the anticancer efficacy of our PTL-fGn complex. Delivery by fGn was found to increase the anticancer/apoptotic effects of PTL (but not DMAPT) when delivered to the human pancreatic cancer cell line, Panc-1. The IC50 value for PTL decreased from 39 µM to 9.5 µM when delivered as a mixture with fGn. The IC50 of DMAPT did not decrease when delivered as DMAPT-fGn and was significantly higher than that for PTL-fGn. There were significant increases in ROS formation and in mitochondrial membrane disruption in Panc-1 cells after PTL-fGn treatment as compared to PTL treatment, alone. Increases in toxicity were also seen with apoptosis detection assays using flow cytometry, ethidium bromide/acridine orange/DAPI staining, and TUNEL. Thus, fGn delivery was successfully used to overcome the poor water solubility of PTL, providing a strategy for improving the effectiveness of this anticancer agent.

An ongoing need for new cancer therapeutics exists, especially ones that specifically home and target triple-negative breast cancer. Because triple-negative breast cancer express low or are devoid of estrogen, progesterone, or Her2/Neu receptors, another target must be used for advanced drug delivery strategies. Here, we engineered a nanodrug delivery system consisting of silver-coated gold nanorods (AuNR/Ag) targeting epithelial cell adhesion/activating molecule (EpCAM) and loaded with doxorubicin. This nanodrug system, AuNR/Ag/Dox-EpCAM, was found to specifically target EpCAM-expressing tumors compared to low EpCAM-expressing tumors. Namely, the nanodrug had an effective dose (ED50) of 3 μM in inhibiting 4T1 cell viability and an ED50 of 110 μM for MDA-MD-231 cells. Flow cytometry data indicated that 4T1 cells, on average, express two orders of magnitude more EpCAM than MDA-MD-231 cells, which correlates with our ED50 findings. Moreover, due to the silver coating, the AuNR/Ag can be detected simultaneously by surface-enhanced Raman spectroscopy and photoacoustic microscopy. Analysis by these imaging detection techniques as well as by inductively coupled plasma mass spectrometry showed that the targeted nanodrug system was taken up by EpCAM-expressing cells and tumors at significantly higher rates than untargeted nanoparticles (p < 0.05). Thus, this approach establishes a plasmonically active nanodrug theranostic for triple-negative breast cancer and, potentially, a delivery platform with improved multimodal imaging capability for other clinically relevant chemotherapeutics with dose-limiting toxicities, such as platinum-based or taxane-based therapies.